Back to Search
DAVID HIRST, MD
MD
Anesthesiology Physician
NPI: 1376686410IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
G47876(CA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE
Class of 1981
Research & Publications (20)
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells.
PMID 19062185·J Gene Med·2009
7-preclinical
Divergent trends in anadromous salmonid populations in Norwegian and Scottish rivers.
PMID 19129101·Proc Biol Sci·2009
7-preclinical
Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma.
PMID 19562576·Cytotherapy·2009
7-preclinical
Cytochrome P450 1B1 expression in rat esophageal tumorigenesis promoted by gastric and duodenal reflux.
PMID 18618592·Mol Carcinog·2009
7-preclinical
Fragmentation and plasmid strand breaks in pure and gold-doped DNA irradiated by beams of fast hydrogen atoms.
PMID 19590119·Phys Med Biol·2009
8-other
Variation of strand break yield for plasmid DNA irradiated with high-Z metal nanoparticles.
PMID 18763863·Radiat Res·2008
8-other
The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?
PMID 18615772·J Gene Med·2008
7-preclinical
Themed issue: radiation biology--can new concepts achieve better treatment outcomes?
PMID 18756613·J Pharm Pharmacol·2008
8-other
Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions.
PMID 18644193·J Pharm Pharmacol·2008
6-review
Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes.
PMID 18669161·Oncol Res·2008
4-observational
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
PMID 18669603·Endocrinology·2008
8-other
Helokinestatin: a new bradykinin B2 receptor antagonist decapeptide from lizard venom.
PMID 18078686·Peptides·2008
7-preclinical
The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
PMID 18256696·Gene Ther·2008
7-preclinical
Metabolites of the radiosensitizer nicotinamide are unlikely to contribute to the degree of emesis observed with the parent drug.
PMID 18351131·Oncol Res·2007
7-preclinical
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
PMID 17471586·J Gene Med·2007
8-other
An organocatalytic oxidative coupling strategy for the direct synthesis of arylated quaternary stereogenic centers.
PMID 17924643·Org Lett·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6969 BROCKTON AVE, SUITE B
RIVERSIDE, CA 92506 - Phone
- (951) 686-3575
Quick Facts
- NPI
- 1376686410
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile